Once integration is completed, the partners plan to accelerate commercial rollout across India, anticipated in 2026.

An AI-powered heart disease test from Chicago firm is expanding to its first international market. Learn more here.

Allergen Alert got my attention at CES. The company, a spin-off of global diagnostics firm, bioMérieux, is trying to make ...

BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a ...

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

RealTime Labs' mycotoxin panel is among the most extensive available and is HSA/FSA-eligible. It also offers an environmental mold and mycotoxin assessment, or EMMA, to test the environment for the ...

InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology ...

Hoping to catch serious illnesses early, more Americans are ordering lab tests online, but their doctors don't know what to ...

Many health insurance plans are required by the Affordable Care Act (ACA) to cover certain STD screenings without ...

A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.